There is increasing evidence that points to the alteration and dysfunction of the cerebral vasculature as an important factor in assessing the pathophysiology of AD, and this process may contribute to the onset of neurodegeneration, inflammation, Aβ accumulation and tau phosphorylation [177,178]. This evidence concerns the gene MAPT and Alzheimer disease.